2021 Form 10-K Financial Statement

#000165495422003008 Filed on March 11, 2022

View on sec.gov

Income Statement

Concept 2021 2020 Q4 2020
Revenue $15.86M $2.154M $8.059M
YoY Change 96.8% -48.78% -37.87%
Cost Of Revenue $5.943M $1.109M $4.435M
YoY Change 34.0% -46.19% -34.94%
Gross Profit $9.917M $1.045M $3.624M
YoY Change 173.65% -51.26% -41.12%
Gross Profit Margin 62.53% 48.51% 44.97%
Selling, General & Admin $6.209M $1.915M $6.741M
YoY Change -7.89% 32.34% 16.53%
% of Gross Profit 62.61% 183.25% 186.01%
Research & Development $0.00 $0.00 $31.00K
YoY Change -100.0% -100.0% -71.82%
% of Gross Profit 0.0% 0.0% 0.86%
Depreciation & Amortization $7.380M $3.020M $11.34M
YoY Change -34.94% 47.61% 2.83%
% of Gross Profit 74.42% 289.0% 313.0%
Operating Expenses $19.53M $4.935M $41.88M
YoY Change -53.36% 38.9% 147.44%
Operating Profit -$1.867M -$3.890M -$33.82M
YoY Change -94.48% 176.08% 214.01%
Interest Expense $1.000K $3.000K $2.000K
YoY Change -50.0% -90.91% -100.26%
% of Operating Profit
Other Income/Expense, Net $568.0K -$181.0K $1.132M
YoY Change -49.82% -1745.45% -1167.92%
Pretax Income -$1.299M -$23.40M -$32.69M
YoY Change -96.03% 1244.0% 194.45%
Income Tax
% Of Pretax Income
Net Earnings -$1.299M -$23.40M -$32.69M
YoY Change -96.03% 1244.0% 194.45%
Net Earnings / Revenue -8.19% -1086.3% -405.63%
Basic Earnings Per Share -$0.02
Diluted Earnings Per Share -$16.24K -$322.9K -$452.7K
COMMON SHARES
Basic Shares Outstanding 20.00 shares 450.0 shares
Diluted Shares Outstanding 79.96M shares

Balance Sheet

Concept 2021 2020 Q4 2020
SHORT-TERM ASSETS
Cash & Short-Term Investments $25.93M $8.027M $8.027M
YoY Change 223.03% -64.19% -64.19%
Cash & Equivalents $8.027M
Short-Term Investments
Other Short-Term Assets $326.0K $66.00K $66.00K
YoY Change 393.94% -9.59% -9.59%
Inventory
Prepaid Expenses
Receivables $1.782M $660.0K $660.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $28.04M $8.753M $8.753M
YoY Change 220.32% -67.69% -67.69%
LONG-TERM ASSETS
Property, Plant & Equipment $66.64M $67.27M $67.27M
YoY Change -0.93% -27.05% -27.05%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.543M $3.543M $3.543M
YoY Change 0.0% -1.53% -1.53%
Total Long-Term Assets $70.18M $70.81M $70.81M
YoY Change -0.89% -26.09% -26.09%
TOTAL ASSETS
Total Short-Term Assets $28.04M $8.753M $8.753M
Total Long-Term Assets $70.18M $70.81M $70.81M
Total Assets $98.22M $79.56M $79.56M
YoY Change 23.45% -35.26% -35.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.626M $212.0K $212.0K
YoY Change 1138.68% -98.25% -98.25%
Accrued Expenses $1.568M $303.0K $408.0K
YoY Change 284.31% -85.36% -80.28%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $288.0K $288.0K
YoY Change -100.0%
Total Short-Term Liabilities $5.181M $1.978M $1.978M
YoY Change 161.93% -87.0% -87.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $82.00K $82.00K
YoY Change -100.0%
Other Long-Term Liabilities $1.557M $1.868M $1.868M
YoY Change -16.65% -14.08% -14.08%
Total Long-Term Liabilities $1.557M $1.950M $1.950M
YoY Change -20.15% -10.3% -10.3%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.181M $1.978M $1.978M
Total Long-Term Liabilities $1.557M $1.950M $1.950M
Total Liabilities $6.738M $3.928M $3.928M
YoY Change 71.54% -77.42% -77.42%
SHAREHOLDERS EQUITY
Retained Earnings -$128.3M
YoY Change
Common Stock $72.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $91.48M $75.64M $75.64M
YoY Change
Total Liabilities & Shareholders Equity $98.22M $79.56M $79.56M
YoY Change 23.45% -35.26% -35.26%

Cashflow Statement

Concept 2021 2020 Q4 2020
OPERATING ACTIVITIES
Net Income -$1.299M -$23.40M -$32.69M
YoY Change -96.03% 1244.0% 194.45%
Depreciation, Depletion And Amortization $7.380M $3.020M $11.34M
YoY Change -34.94% 47.61% 2.83%
Cash From Operating Activities $5.970M $36.00K $12.00K
YoY Change 49650.0% -100.75% -99.28%
INVESTING ACTIVITIES
Capital Expenditures -$4.632M -$391.0K -$14.77M
YoY Change -68.64% -94.17% -63.89%
Acquisitions
YoY Change
Other Investing Activities $1.871M $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$2.761M -$391.0K -$14.77M
YoY Change -81.31% -94.17% -62.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $14.69M $0.00
YoY Change -100.0%
Debt Paid & Issued, Net $0.00 $370.0K
YoY Change -100.0%
Cash From Financing Activities $14.69M 0.000 $370.0K
YoY Change 3871.35% -99.36%
NET CHANGE
Cash From Operating Activities $5.970M 36.00K $12.00K
Cash From Investing Activities -$2.761M -391.0K -$14.77M
Cash From Financing Activities $14.69M 0.000 $370.0K
Net Change In Cash $17.90M -355.0K -$14.39M
YoY Change -224.43% -96.92% -172.18%
FREE CASH FLOW
Cash From Operating Activities $5.970M $36.00K $12.00K
Capital Expenditures -$4.632M -$391.0K -$14.77M
Free Cash Flow $10.60M $427.0K $14.78M
YoY Change -28.28% -77.29% -65.28%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 dei Auditor Location
AuditorLocation
Houston, Texas
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25930000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8027000 USD
CY2021Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
1782000 USD
CY2020Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
660000 USD
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
326000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
66000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
28038000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
8753000 USD
CY2021Q4 us-gaap Oil And Gas Property Full Cost Method Gross
OilAndGasPropertyFullCostMethodGross
63908000 USD
CY2020Q4 us-gaap Oil And Gas Property Full Cost Method Gross
OilAndGasPropertyFullCostMethodGross
66994000 USD
CY2021Q4 us-gaap Capitalized Costs Of Unproved Properties Excluded From Amortization Cumulative
CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationCumulative
2559000 USD
CY2020Q4 us-gaap Capitalized Costs Of Unproved Properties Excluded From Amortization Cumulative
CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationCumulative
4000 USD
CY2021Q4 us-gaap Oil And Gas Property Full Cost Method Net
OilAndGasPropertyFullCostMethodNet
66467000 USD
CY2020Q4 us-gaap Oil And Gas Property Full Cost Method Net
OilAndGasPropertyFullCostMethodNet
66998000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
173000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
270000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3543000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3543000 USD
CY2021Q4 us-gaap Assets
Assets
98221000 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
114000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
105000 USD
CY2021Q4 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
49000 USD
CY2020Q4 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
234000 USD
CY2020Q4 us-gaap Assets
Assets
79564000 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2626000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
212000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1454000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
303000 USD
CY2021Q4 ped Revenue Payable
RevenuePayable
938000 USD
CY2020Q4 ped Revenue Payable
RevenuePayable
836000 USD
CY2021Q4 us-gaap Loans Payable Current
LoansPayableCurrent
0 USD
CY2020Q4 us-gaap Loans Payable Current
LoansPayableCurrent
288000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5181000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1978000 USD
CY2021Q4 us-gaap Oil And Gas Reclamation Liability Noncurrent
OilAndGasReclamationLiabilityNoncurrent
0 USD
CY2020Q4 us-gaap Oil And Gas Reclamation Liability Noncurrent
OilAndGasReclamationLiabilityNoncurrent
82000 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
81000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
195000 USD
CY2021Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
1476000 USD
CY2020Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
1673000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
6738000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
3928000 USD
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
84236146 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
72463340 shares
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
84000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
72000 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
220984000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
203850000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-129585000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-128286000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
91483000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
75636000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
98221000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
79564000 USD
CY2021 us-gaap Revenues
Revenues
15860000 USD
CY2020 us-gaap Revenues
Revenues
8059000 USD
CY2021 us-gaap Lease Cost
LeaseCost
5943000 USD
CY2020 us-gaap Lease Cost
LeaseCost
4435000 USD
CY2021 us-gaap Exploration Expense
ExplorationExpense
0 USD
CY2020 us-gaap Exploration Expense
ExplorationExpense
31000 USD
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6209000 USD
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6741000 USD
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
7380000 USD
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
11343000 USD
CY2021 us-gaap Impairment Of Oil And Gas Properties
ImpairmentOfOilAndGasProperties
0 USD
CY2020 us-gaap Impairment Of Oil And Gas Properties
ImpairmentOfOilAndGasProperties
19331000 USD
CY2021 us-gaap Operating Expenses
OperatingExpenses
19532000 USD
CY2020 us-gaap Operating Expenses
OperatingExpenses
41881000 USD
CY2021 us-gaap Proceeds From Sale Of Oil And Gas Property And Equipment
ProceedsFromSaleOfOilAndGasPropertyAndEquipment
1805000 USD
CY2020 us-gaap Proceeds From Sale Of Oil And Gas Property And Equipment
ProceedsFromSaleOfOilAndGasPropertyAndEquipment
0 USD
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-1867000 USD
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1132000 USD
CY2021 ped Increase Decrease On Gains Losses On Extinguishment Of Debt
IncreaseDecreaseOnGainsLossesOnExtinguishmentOfDebt
-374000 USD
CY2020 ped Increase Decrease On Gains Losses On Extinguishment Of Debt
IncreaseDecreaseOnGainsLossesOnExtinguishmentOfDebt
0 USD
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
568000 USD
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-33822000 USD
CY2021 us-gaap Interest Expense
InterestExpense
1000 USD
CY2020 us-gaap Interest Expense
InterestExpense
2000 USD
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
15000 USD
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
40000 USD
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
180000 USD
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1094000 USD
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
374000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1299000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-32690000 USD
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20.00 shares
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
450 shares
CY2021 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-20.00 USD
CY2020 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-450 USD
CY2021 ped Basic New
BasicNew
79963237000 USD
CY2020 ped Basic New
BasicNew
72209553000 USD
CY2021 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
79963237000 shares
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
72209553000 shares
CY2021 us-gaap Profit Loss
ProfitLoss
-1299000 USD
CY2020 us-gaap Profit Loss
ProfitLoss
-32690000 USD
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7380000 USD
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11343000 USD
CY2021 us-gaap Impairment Of Oil And Gas Properties
ImpairmentOfOilAndGasProperties
0 USD
CY2020 us-gaap Impairment Of Oil And Gas Properties
ImpairmentOfOilAndGasProperties
19331000 USD
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
2452000 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
2824000 USD
CY2021 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
CY2020 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
24000 USD
CY2021 us-gaap Gain Loss On Sale Of Oil And Gas Property
GainLossOnSaleOfOilAndGasProperty
-1805000 USD
CY2020 us-gaap Gain Loss On Sale Of Oil And Gas Property
GainLossOnSaleOfOilAndGasProperty
0 USD
CY2021 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
97000 USD
CY2020 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
90000 USD
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1122000 USD
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3942000 USD
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-260000 USD
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
7000 USD
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-356000 USD
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3199000 USD
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1155000 USD
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1669000 USD
CY2021 ped Increase Decrease Accrued Expenses To Related Party
IncreaseDecreaseAccruedExpensesToRelatedParty
0 USD
CY2020 ped Increase Decrease Accrued Expenses To Related Party
IncreaseDecreaseAccruedExpensesToRelatedParty
0 USD
CY2021 ped Increase Decrease Revenue Payable
IncreaseDecreaseRevenuePayable
102000 USD
CY2020 ped Increase Decrease Revenue Payable
IncreaseDecreaseRevenuePayable
9000 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5970000 USD
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
12000 USD
CY2021 ped Cash Paid For Drilling Costs
CashPaidForDrillingCosts
-4597000 USD
CY2020 ped Cash Paid For Drilling Costs
CashPaidForDrillingCosts
-14770000 USD
CY2021 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
35000 USD
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 USD
CY2020 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
0 USD
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
2824000 USD
CY2020 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
0 USD
CY2021 ped Increase Decrease On Proceeds From Sale Of Oil And Gas Property And Equipment
IncreaseDecreaseOnProceedsFromSaleOfOilAndGasPropertyAndEquipment
1871000 USD
CY2020 ped Increase Decrease On Proceeds From Sale Of Oil And Gas Property And Equipment
IncreaseDecreaseOnProceedsFromSaleOfOilAndGasPropertyAndEquipment
0 USD
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2761000 USD
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-14770000 USD
CY2021 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
0 USD
CY2020 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
740000 USD
CY2021 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
CY2020 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
370000 USD
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
14694000 USD
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
14694000 USD
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
370000 USD
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
17903000 USD
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-14388000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25712000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29227000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11324000 USD
CY2021 us-gaap Interest Paid
InterestPaid
0 USD
CY2020 us-gaap Interest Paid
InterestPaid
0 USD
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2021 ped Accrued Oil And Gas Development Costs
AccruedOilAndGasDevelopmentCosts
2412000 USD
CY2020 ped Accrued Oil And Gas Development Costs
AccruedOilAndGasDevelopmentCosts
8827000 USD
CY2021 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
319000 USD
CY2020 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
439000 USD
CY2021 ped Issuance Of Restricted Common Stock
IssuanceOfRestrictedCommonStock
1000 USD
CY2020 ped Issuance Of Restricted Common Stock
IssuanceOfRestrictedCommonStock
1000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
105502000 USD
CY2020 ped Restricted Stock Issued During Period Value New Issues
RestrictedStockIssuedDuringPeriodValueNewIssues
0 USD
CY2020 ped Stock Rescinded During Period Value
StockRescindedDuringPeriodValue
0 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-32690000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
75636000 USD
CY2021 ped Restricted Stock Issued During Period Value New Issues
RestrictedStockIssuedDuringPeriodValueNewIssues
0 USD
CY2021 ped Stock Rescinded During Period Value
StockRescindedDuringPeriodValue
0 USD
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
14694000 USD
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 USD
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
2452000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1299000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
91483000 USD
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;"><strong>Use of Estimates in Financial Statement Preparation. </strong>The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, as well as certain financial statement disclosures. While management believes that the estimates and assumptions used in the preparation of the financial statements are appropriate, actual results could differ from these estimates. Significant estimates generally include those with respect to the amount of recoverable oil and gas reserves, the fair value of financial instruments, oil and gas depletion, asset retirement obligations, and stock-based compensation.</p>
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;"><strong>Concentrations of Credit Risk. </strong>Financial instruments which potentially subject the Company to concentrations of credit risk include cash deposits placed with financial institutions. The Company periodically assesses the financial condition of its financial institutions and considers any possible credit risk to be minimal.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">Sales to two customers comprised 72% and 12%, respectively, of the Company’s total oil and gas revenues for the year ended December 31, 2021. The Company believes that, in the event that its primary customers are unable or unwilling to continue to purchase the Company’s production, there are a substantial number of alternative buyers for its production at comparable prices.</p>
CY2021Q4 us-gaap Other Receivables
OtherReceivables
17000000 USD
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1123435 shares
CY2020Q4 ped Asset Retirement Costs
AssetRetirementCosts
1108 USD
CY2021Q4 ped Asset Retirement Costs
AssetRetirementCosts
789 USD
CY2019Q4 us-gaap Oil And Gas Property Successful Effort Method Accumulated Depreciation Depletion And Amortization
OilAndGasPropertySuccessfulEffortMethodAccumulatedDepreciationDepletionAndAmortization
126114000 USD
CY2020Q4 us-gaap Oil And Gas Property Successful Effort Method Accumulated Depreciation Depletion And Amortization
OilAndGasPropertySuccessfulEffortMethodAccumulatedDepreciationDepletionAndAmortization
146950000 USD
CY2019Q4 ped Oil And Gas Property Successful Effort Method Not Accumulated Depreciation Depletion And Amortization
OilAndGasPropertySuccessfulEffortMethodNotAccumulatedDepreciationDepletionAndAmortization
14896000 USD
CY2020Q4 ped Oil And Gas Property Successful Effort Method Not Accumulated Depreciation Depletion And Amortization
OilAndGasPropertySuccessfulEffortMethodNotAccumulatedDepreciationDepletionAndAmortization
4000 USD
CY2019Q4 ped Asset Retirement Costs
AssetRetirementCosts
1547 USD
CY2020Q4 ped Asset Retirement Costs
AssetRetirementCosts
1108 USD
CY2019Q4 us-gaap Oil And Gas Property Successful Effort Method Accumulated Depreciation Depletion Amortization And Impairment
OilAndGasPropertySuccessfulEffortMethodAccumulatedDepreciationDepletionAmortizationAndImpairment
50709000 USD
CY2020Q4 us-gaap Oil And Gas Property Successful Effort Method Accumulated Depreciation Depletion Amortization And Impairment
OilAndGasPropertySuccessfulEffortMethodAccumulatedDepreciationDepletionAmortizationAndImpairment
81064000 USD
CY2019Q4 us-gaap Oil And Gas Property Full Cost Method Net
OilAndGasPropertyFullCostMethodNet
91848000 USD
CY2020Q4 us-gaap Oil And Gas Property Full Cost Method Net
OilAndGasPropertyFullCostMethodNet
66998000 USD
CY2021 ped Purchase Price Payment
PurchasePricePayment
52000 USD
CY2020 ped Capital Costs Incurred Recently Completed Wells
CapitalCostsIncurredRecentlyCompletedWells
5943000 USD
CY2021 ped Capital Costs For Which Production Not Started
CapitalCostsForWhichProductionNotStarted
15294000 USD
CY2020 us-gaap Impairment Of Oil And Gas Properties
ImpairmentOfOilAndGasProperties
19331000 USD
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
16667 shares
CY2021Q1 ped Underwriter Discount Percent
UnderwriterDiscountPercent
0.06 pure
CY2021Q1 ped Net Proceeds
NetProceeds
8200000 USD
CY2021Q4 us-gaap Shares Outstanding
SharesOutstanding
4458600 shares
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1.57
CY2021Q4 ped Net Proceeds
NetProceeds
6500000 USD
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
1499000 shares
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
129000 shares
CY2021Q4 ped Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
0.32
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
150329 shares
CY2020Q4 ped Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
0.32
CY2020Q4 ped Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instuments Other Than Options Exercisable Intrinsic Value
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstumentsOtherThanOptionsExercisableIntrinsicValue
179000 USD
CY2021Q1 ped Shares Of Restricted Common Stock
SharesOfRestrictedCommonStock
16667 shares
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
55000 shares
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
74000 shares
CY2021Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
1919000 USD
CY2020Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
2323000 USD
CY2021Q4 ped Unamortized Stock Based Compensation Expense Restricted Stock Option
UnamortizedStockBasedCompensationExpenseRestrictedStockOption
866000 USD
CY2020Q4 ped Unamortized Stock Based Compensation Expense Restricted Stock Option
UnamortizedStockBasedCompensationExpenseRestrictedStockOption
1144000 USD
CY2021Q1 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
550000 shares
CY2021Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.39
CY2021Q1 us-gaap Contract Termination Claims Description
ContractTerminationClaimsDescription
The options have a term of five years and fully vest in January 2024, with 33.3% vesting each subsequent year from the date of grant, contingent upon each recipient’s continued service with the Company
CY2021Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
654000 USD
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Discount For Postvesting Restrictions
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions
0.0045 pure
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y6M
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.56 pure
CY2021Q1 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
86430 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
191999 shares
CY2021Q1 ped Coomon Stock Market Value
CoomonStockMarketValue
2.89
CY2021Q1 ped Aggregate Intrinsic Value Of Options
AggregateIntrinsicValueOfOptions
250000 USD
CY2021Q4 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
52943 shares
CY2020Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.68
CY2020Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
1053000 USD
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Discount For Postvesting Restrictions
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions
0.0163 pure
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y6M
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
214000 shares
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
2.00
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
266999 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.23
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
37500 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
75000 shares
CY2021Q4 us-gaap Option Indexed To Issuers Equity Strike Price1
OptionIndexedToIssuersEquityStrikePrice1
0.3088
CY2021Q4 ped Coomon Stock Market Value
CoomonStockMarketValue
1.05
CY2021Q4 ped Aggregate Intrinsic Value Of Options
AggregateIntrinsicValueOfOptions
56000 USD
CY2020Q1 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
733000 shares
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.55 pure
CY2020Q3 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
32012 shares
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
37500 shares
CY2020Q3 us-gaap Option Indexed To Issuers Equity Strike Price1
OptionIndexedToIssuersEquityStrikePrice1
0.3088
CY2020Q3 ped Coomon Stock Market Value
CoomonStockMarketValue
2.11
CY2020Q3 ped Aggregate Intrinsic Value Of Options
AggregateIntrinsicValueOfOptions
68000 USD
CY2021 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
533000000 USD
CY2020 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
501000000 USD
CY2021Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
287000 USD
CY2020Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
315000 USD
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 USD
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
121000000 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.43
CY2021 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P2Y8M12D
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
753349 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.93
CY2020 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P2Y6M
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
550000 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.39
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
733000 shares
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.68
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
394415 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
3.57
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.31
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1123435 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.80
CY2021 ped Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2a
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2a
P3Y
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1234849 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.43
CY2020 ped Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2a
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2a
P2Y8M12D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
366101 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.42
CY2021 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P1Y8M12D
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
720016 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.08
CY2020 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P1Y7M6D
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0664 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0664 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Amortization
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization
0.0000 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Amortization
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization
0.0000 pure
CY2021 ped Meals And Entertainment
MealsAndEntertainment
-0.0003 pure
CY2020 ped Meals And Entertainment
MealsAndEntertainment
0.0000 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Deductions Other
EffectiveIncomeTaxRateReconciliationDeductionsOther
0.0795 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation Deductions Other
EffectiveIncomeTaxRateReconciliationDeductionsOther
0.0000 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Life Insurance
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLifeInsurance
0.0573 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Life Insurance
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLifeInsurance
0.0020 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.0650 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.0002 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.0000 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.0000 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.3633 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.2746 pure
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0000 pure
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0000 pure
CY2021Q4 ped Deferred Tax Assets Difference In Depreciation Depletion And Capitalization Methods Oil And Natural Gas Properties
DeferredTaxAssetsDifferenceInDepreciationDepletionAndCapitalizationMethodsOilAndNaturalGasProperties
2389000 USD
CY2020Q4 ped Deferred Tax Assets Difference In Depreciation Depletion And Capitalization Methods Oil And Natural Gas Properties
DeferredTaxAssetsDifferenceInDepreciationDepletionAndCapitalizationMethodsOilAndNaturalGasProperties
712000 USD
CY2021Q4 ped Deferred Tax Assets Tax Accretion
DeferredTaxAssetsTaxAccretion
132000 USD
CY2020Q4 ped Deferred Tax Assets Tax Accretion
DeferredTaxAssetsTaxAccretion
80000 USD
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses
5343000 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses
5343000 USD
CY2021Q4 us-gaap Lease Deposit Liability
LeaseDepositLiability
56 USD
CY2020Q4 us-gaap Lease Deposit Liability
LeaseDepositLiability
0 USD
CY2021Q4 ped Rou Assets
RouAssets
52 USD
CY2020Q4 ped Rou Assets
RouAssets
0 USD
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Other
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther
1000 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Other
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther
1000 USD
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1149000 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
975000 USD
CY2021Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
24422000 USD
CY2020Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
25507000 USD
CY2021Q4 ped Net Operating Losses State Taxes
NetOperatingLossesStateTaxes
3531000 USD
CY2020Q4 ped Net Operating Losses State Taxes
NetOperatingLossesStateTaxes
3874000 USD
CY2021Q4 us-gaap Deferred Tax Assets Gross Noncurrent
DeferredTaxAssetsGrossNoncurrent
36963000 USD
CY2020Q4 us-gaap Deferred Tax Assets Gross Noncurrent
DeferredTaxAssetsGrossNoncurrent
36492000 USD
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
36963000 USD
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
36492000 USD
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2021 ped Ownership Change Percent
OwnershipChangePercent
0.50 pure
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
471000000 USD
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
116000000000 USD
CY2021 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Expense
UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense
95000000 USD
CY2021 ped Not Utilized Will Begin Expiring In2038
NotUtilizedWillBeginExpiringIn2038
21000000 USD
CY2021 ped Taxable Income Percent
TaxableIncomePercent
0.80 pure

Files In Submission

Name View Source Status
0001654954-22-003008-index-headers.html Edgar Link pending
0001654954-22-003008-index.html Edgar Link pending
0001654954-22-003008.txt Edgar Link pending
0001654954-22-003008-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
ped-20211231.xsd Edgar Link pending
ped-20211231_cal.xml Edgar Link unprocessable
ped-20211231_def.xml Edgar Link unprocessable
ped-20211231_lab.xml Edgar Link unprocessable
ped-20211231_pre.xml Edgar Link unprocessable
ped_10k.htm Edgar Link pending
ped_10kimg1.jpg Edgar Link pending
ped_10kimg2.jpg Edgar Link pending
ped_10kimg3.jpg Edgar Link pending
ped_10kimg4.jpg Edgar Link pending
ped_10kimg5.jpg Edgar Link pending
ped_10k_htm.xml Edgar Link completed
ped_ex211.htm Edgar Link pending
ped_ex231.htm Edgar Link pending
ped_ex232.htm Edgar Link pending
ped_ex232img2.jpg Edgar Link pending
ped_ex311.htm Edgar Link pending
ped_ex312.htm Edgar Link pending
ped_ex321.htm Edgar Link pending
ped_ex322.htm Edgar Link pending
ped_ex991.htm Edgar Link pending
ped_ex991img1.jpg Edgar Link pending
ped_ex991img2.jpg Edgar Link pending
ped_ex991img3.jpg Edgar Link pending
ped_ex991img4.jpg Edgar Link pending
ped_ex991img5.jpg Edgar Link pending
ped_ex991img6.jpg Edgar Link pending
ped_ex991img7.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending